BioSpace News Archive

Moleculin Biotech, Inc. today announced that it has received approval from the United Kingdom’s (UK) MHRA to proceed with a first-in-human Phase 1a study to evaluate the safety and pharmacokinetics of WP1122 in healthy volunteers for the treatment of COVID-19 (MB-301).

ReAlta Life Sciences (“ReAlta”), Inc., today announced the company secured regulatory approval from Germany’s Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) to conduct a Phase 1b inhaled lipopolysaccharide (LPS) challenge clinical trial in healthy volunteers to support development of the Company’s lead compound, RLS-0071, in severe asthma.

Transcat, Inc. announced that it will release its fourth quarter and full fiscal year 2022 results after the close of financial markets on Monday, May 23, 2022.

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in May. BofA Securities 2022 Healthcare Conference on Thursday, May 12 at 3:00 p.m. ET UBS Global Healthcare Conference on Tuesday, May 24 at 2:00 p.m. ET.

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), announces that the phase I trial interim results of an investigator-initiated trial of CT041 have been published in Nature Medicine (https://www.nature.com/articles/s41591-022-01800-8), which is one of the top international medical journals in the Nature Portfolio (2-year Impact Factor of 53.44).

Debbie’s Dream Foundation: Curing Stomach Cancer and the Korean Cancer Association will partner to host the 2nd International Gastric Cancer Educational Symposium.

Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction.

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd (NSI), an established distributor of laboratory animals and related products, as its preferred distributor in India.

Alpha Pro Tech, Ltd. announced financial results for the three month period ended March 31, 2022.

Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for claims that cover certain methods for the treatment of autoimmune inflammatory mastitis that can be achieved by its product candidate, CLAR-121, a proprietary combination of testosterone (T) and anastrozole delivered by a subcutaneous implant.